The recent and long-term insider transactions suggest a bull...
The recent and long-term insider transactions suggest a bullish sentiment among insiders towards HCW Biologics, despite the company making losses. The high insider ownership indicates that the company is likely run in the interest of all shareholders.
Chief Financial Officer of HCW Biologics Rebecca Byam Buys 122% More Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment